News

Sep 6

MitoSense Applauds Elliott Mitochondria Research Center's Benefit Concert: A Night to END ALS & TBI

September 6, 2024 – Tampa, FL – MitoSense, holder of an exclusive license on groundbreaking technology from the Elliott Mitochondria...

Aug 19

MitoSense to Attend MHSRS, August 26th -29th

MitoSense, Inc. is proud to announce its participation in the 2024 Military Health System Research Symposium (MHSRS), taking place August...

Jul 29

MitoSense is Accepted into NVIDIA's Inception Program

We are thrilled to announce that MitoSense Inc. has been accepted into the prestigious NVIDIA Inception Program! This milestone marks a...

Jun 13

MitoSense Chief Medical Officer Submits Statement for the Record to U.S. House VA Committee Hearing

MitoSense's Chief Medical Officer, Dr. Catherine Baucom, has been invited to provide a Statement for the Record for the U.S. House of...

Jan 30

Hop On A Cure Foundation Announces Investment in MitoSense’s MOT™ Technology to Revolutionize ALS Treatment

SOURCE: Hop On A Cure ATLANTA, Ga. (January 30, 2024) - Nonprofit foundation Hop On A Cure, a leading advocate in the fight against ALS,...

Jan 25

MitoSense and Uppsala University, in Collaboration with Elliott Mitochondrial Center and Sallie Astor Burdine Breast Foundation, Announce Breakthrough in Mitochondrial Preservation

PLYMOUTH, Mass., Jan. 25, 2024 /PRNewswire/ -- MitoSense Inc., a leading innovator in biotechnology with a focus on neurodegenerative...

Jan 23

SC Governor Henry McMaster Speaks at Ribbon Cutting for Carroll A. Campbell, Jr. Alzheimer’s Initiative

On January 22, 2024, MitoSense reached an exciting milestone in its fight to treat neurodegenereagtive diseases with the ribbon cutting...

Jan 22

MitoSense Inc. Completes $3.5 Million Series Seed Funding Round, Led by Caydan Capital Partners

PLYMOUTH, Mass., Jan. 22, 2024 /PRNewswire/ -- MitoSense Inc., a research and development company focused on neurodegenerative disease...